Loading...
Loading...
OGN| Name | Value |
|---|---|
| Revenues | 1,538.0M |
| Cost of Revenue | 580.0M |
| Gross Profit | 958.0M |
| Operating Expense | 564.0M |
| Operating I/L | 331.0M |
| Other Income/Expense | -96.0M |
| Interest Income | 132.0M |
| Pretax | 235.0M |
| Income Tax Expense | 58.0M |
| Net Income/Loss | 177.0M |
Organon & Co. is a health care company that develops and delivers a portfolio of prescription therapies globally. Its products include women's health solutions such as contraception and fertility brands, biosimilars for immunology and oncology, cardiovascular medicines, respiratory treatments, dermatology products, bone health solutions, non-opioid pain management products, and treatments for benign prostatic hyperplasia and male pattern hair loss. The company sells its products to drug wholesalers, retailers, hospitals, government agencies, and managed health care providers, generating revenue through the sale of prescription therapies and health solutions.
